Substance P and Calcitonin Gene‐Related Peptide (CGRP) in Gastrointestinal Inflammation

Annals of the New York Academy of Sciences

Volumn 664, Issue 1, 1992, Pages 425-442

  SHARKEY, KEITH A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; CALCITONIN GENE RELATED PEPTIDE; INDOMETACIN; SUBSTANCE P; SUBSTANCE P ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR;

ANTIDROMIC STIMULATION; CONFERENCE PAPER; DIGESTIVE SYSTEM INFLAMMATION; ENTERITIS; GASTRITIS; INTESTINE INNERVATION; NERVE STIMULATION; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE; TISSUE DISTRIBUTION;

AFFERENT PATHWAYS; ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; ENTERITIS; GASTROINTESTINAL SYSTEM; HUMAN; INFLAMMATORY BOWEL DISEASES; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0027103970     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1992.tb39781.x     Document Type: Article

References (125)

1. Acute and chronic inflammation
2. Sir Thomas Lewis's nocifensor system, histamine and substance‐P‐containing primary afferent nerves
3. Substance Pas neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation
4. The neuropharmacology of capsaicin: review of some recent observations
5. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons
6. Gut tachykinins
7. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms
8. Tachykinin and calcitonin gene‐related peptide immunoreactivities and mRNAs in the mammalian enteric nervous system and sensory ganglia
9. Inhibition of neurogenic Vasodilatation and plasma extravasation by substance P antagonists, somatostatin and (D‐Met2, Pro5)‐enkephalinamide
10. A substance P antagonist inhibits heat‐induced oedema in the rat skin
11. Local effector functions of capsaicin‐sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene‐related peptide and other neuro‐peptides
12. The role of substance P and calcitonin gene‐related peptide in neurogenic plasma extravasation and Vasodilatation in the rat
13. Pharmacological properties of a potent and selective nonpeptide substance P antagonist
14. Characterization of neuropeptide‐induced histamine release from human dispersed skin mast cells
15. Substance P‐induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent
16. Neurogenic inflammation, vascular permeability, and mast cells
17. Neuroimmunomodulation in the intestinal mucosa
18. Neuropeptides and inflammation: the role of substance P
19. The tachykinin neuroimmune connection in inflammatory pain
20. Immunomodulation by tachykinin neuropeptides
21. Substance P and the inflammatory and immune response
22. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
23. Production of a novel neuropeptide encoded by the calcitonin gene via tissue‐specific RNA processing
24. Calcitonin gene‐related peptide in the nervous tissue
25. Immunoreactive calcitonin gene‐related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat
26. Distribution of calcitonin gene‐related peptide in the rat peripheral nervous system with reference to its coexistence with substance P
27. Calcitonin gene‐related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat
28. Co‐localization of calcitonin gene‐related peptide‐like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs
29. Pathway‐specific patterns of the co‐existence of substance P, calcitonin gene‐related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea‐pig
30. Calcitonin gene‐related peptide is a potent vasodilator
31. Inflammatory oedema induced by synergism between calcitonin gene‐related peptide (CGRP) and mediators of increased vascular permeability
32. Time‐dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene‐related peptide (CGRP) and mediators of inflammation
33. Antibodies to calcitonin‐gene related peptide reduce inflammation induced by topical mustard oil but not that due to carrageenin in the rat
34. Immunization with calcitonin gene‐related peptide reduces the inflammatory response to adjuvant arthritis in the rat
35. Interactions between the tachykinins and calcitonin gene‐related peptide lead to the modulation of oedema formation and blood flow in rat skin
36. Substance P regulates the vasodilator activity of calcitonin gene‐related peptide
37. Calcitonin gene‐related peptide is a potent inhibitor of substance P degradation
38. Characterization of the calcitonin gene‐related peptide receptor in mouse T lymphocytes
39. Characterization of functional calcitonin gene‐related peptide receptors on rat lymphocytes
40. Characterization of calcitonin gene‐related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388 D1
41. The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes
42. Inhibition of mitogen‐stimulated T lymphocyte proliferation by calcitonin gene‐related peptide
43. Effects of calcitonin gene‐related peptide (CGRP), neurokinin A and neurokinin A(4‐10) on the mitogenic response of human peripheral blood mononuclear cells
44. Inhibition of mouse T‐cell proliferation by CGRP and VIP: effects of these neuropeptides on IL‐2 production and cAMP synthesis
45. Peptides encoded by the calcitonin gene inhibit macrophage function
46. Eosinophil chemotactic response to rat CGRP‐1 is increased after exposure to trypsin or guinea‐pig lung particulate fraction
47. Inflammatory cells and the epithelium
48. Neuropeptides in the pathogenesis of lung inflammation
49. The contribution of the nervous system to inflammation and inflammatory disease
50. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides
51. Putative mediators in inflammatory bowel disease: substance P and calcitonin gene‐related peptide
52. Structural and chemical organization of the myenteric plexus
53. Histochemistry of the enteric nervous system
54. Chemical coding of neurons in the gastrointestinal tract
55. Vagal afferent innervation of the gastrointestinal tract
56. Simultaneous labeling of vagal innervation of the gut and afferent projections from the visceral forebrain with dil injected into the dorsal vagal complex in the rat
57. Neurochemistry of visceral afferent neurones
58. The afferent peptidergic innervation of the upper gastrointestinal tract
59. Differential expression of alpha‐CGRP and beta‐CGRP by primary sensory neurons and enteric autonomic neurons of the rat
60. Occurrence and distribution of substance P‐ and CGRP‐containing nerve fibres in gastric mucosa
61. Peptides in the gastrointestinal tract in HIV infection
62. Distribution of Certain peptide‐containing nerve fires and endocrine cells in the gastrointestinal mucosa in five mammalian species
63. Substance P‐containing nerve fibers are numerous in human but not in feline intestinal mucosa
64. Localization of calcitonin gene‐related peptide‐like immunoreactivity in neurons of the rat gastrointestinal tract
65. Sensory substance P innervation of the stomach and pancreas
66. Intestinal mucosal mast cells in normal and nematode‐infected rat intestines are in intimate contact with peptidergic nerves
67. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa
68. Immunohistochemical demonstration of peptidergic nerve fibers associated with the central lacteal lymphatics in the duodenal villi of dogs
69. Multiple neuropeptides in nerves supplying mammalian lymph nodes; messenger candidates for sensory and autonomic neuroimmunomodulation
70. Distribution and characterization of calcitonin gene‐related peptide‐immunoreactivity in the digestive system of normal and capsaicin treated rats
71. Distribution and origin of calcitonin gene‐related peptide in the rat stomach and duodenum: an immunocytochemical analysis
72. Calcitonin gene‐related peptide and substance P in afferents to the upper gastrointestinal tract in the rat
73. Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse and guinea pig
74. Sensory innervation of the viscera
75. Role of peptidergic sensory neurons in gastric mucosal blood flow and protection
76. Impaired defense mechanism to peptic ulcer in the capsaicin desensitized rat
77. Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury
78. Neuropeptide distribution in the cervico‐thoracic paravertebral ganglia of the cat with particular reference to calcitonin gene‐related peptide immunoreactivity
79. Morphine potentiation of ethanol‐induced gastric mucosal damage in the rat
80. Evidence for a role of adrenals in the capsaicin‐sensitive “gastric defence mechanism” in rats
81. Local opioid‐sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf
82. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol‐induced damage of gastric mucosa
83. Afferent nerve‐mediated protection against deep mucosal damage in the rat stomach
84. Intragastric capsaicin protects against aspirin‐induced lesion formation and bleeding in the rat gastric mucosa
85. Peptides and their receptors on afferent neurons to the upper gastrointestinal tract
86. The role of calcitonin gene‐related peptide in gastric mucosal protection in the rat
87. Close arterial infusion of calcitonin gene‐related peptide into the rat stomach inhibits aspirin‐ and ethanol‐induced hemorrhagic damage
88. Tachykinins protect against ethanol‐induced gastric lesions in rats
89. Anti‐ulcer activity of calcitonin gene‐related peptide in rats
90. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer
91. Substance P antagonists release histamine from peritoneal mast cells
92. Role of neuropeptides in gastric acid secretion
93. Neural stimulation of gastric bicarbonate secretion in the cat. An involvement of vagal axon‐reflexes and substance P
94. Capsaicin‐sensitive vagal afferent fibers and gastric motility: evidence for an “axon‐reflex mechanism”
95. Inhibition of antidromically induced stimulation of gastric motility by substance P receptor blockade
96. The myenteric plexus in regional enteritis; a study of the number of ganglion cells in the ileum in 24 cases
97. Gut neuropeptides and the pathophysiology of inflammatory bowel disease
98. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation
99. Peptide‐containing nerve fibres in the gut wall in Crohn's disease
100. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease
101. Duodenal ulcers are associated with a depletion of duodenal calcitonin gene‐related pep‐tide‐like immunoreactivity in rats
102. Allergic reactions of rat jejenual mucosa
103. Calcitonin gene‐related peptide and substance P decrease in the rabbit colon during colitis
104. Acute effect of substance P in immunologic vasculitis in the rat colon
105. Increased levels of substance P in the myenteric plexus of trichinella‐infected rats
106. Influence of capsaicin‐sensitive fibres on experi‐mentally‐induced colitis in rats
107. Inflammatory mediators of experimental colitis in rats
108. Hapten‐induced model of chronic inflammation and ulceration in the rat colon
109. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
110. Interleukin‐1 specifically increases substance P in injured sympathetic ganglia
111. Effects of lymphokines on substance P in injured ganglia of the peripheral nervous system
112. An electrophysiological and anatomical study of intestinal afferent fibres in the rat
113. Substance P, 5‐hydroxytrptamine, and bradykinin stimulate abdominal visceral afferents
114. Activation of unmyelinated afferent fibres by mechanical stimulation and inflammation of the urinary bladder in the cat
115. Substance P increases and prolongs increased output of T4 (CD4) lymphocytes from lymph nodes of sheep in vivo: is it a mediator of immunological memory
116. The effect of substance P on the regional lymph node antibody response to antigenic stimulation in capsaicin‐pretreated rats
117. Altered lymphocyte proliferation of immunized rats after neurological manipulation with capsaicin
118. Priming effects of mammalian tachykinins on human neutrophils
119. DNA synthesis induced by the neuropeptide substance K correlates to the level of myc‐gene transcripts
120. Induction of c‐fos‐like protein in spinal cord neurons following sensory stimulation
121. Expression of c‐fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation
122. Release of substance P by granuloma eosinophils in response to secretagogues in murine Schistosomiasis mansoni